Lawsuit Information Center

October 1, 2026

Monsanto Roundup Lawsuit Update

by Ronald V. Miller, Jr.

In this post, our Roundup lawyers will give you:

An update on where things stand in the new $7.5 billion Roundup class action lawsuit settlement in October 2026
The likely direction the Roundup litigation will take moving forward, and

October 1, 2026

Camp Lejeune Lawsuit News and Updates

by Ronald V. Miller, Jr.

This page provides updates on Camp Lejeune lawsuits. Our lawyers are still working to give the latest update on the litigation, even though we are no longer taking new cases. Why? Because there is little information out there, and we are staying with victims, including those we do not represent, until the end.

We have also recently reopened the comments below to answer any questions you may have or simply give you a chance to share your thoughts.

Latest Camp Lejeune Lawsuit Updates for 2026

October 1, 2026

Philadelphia Sexual Abuse Lawsuits and Lawyers

by Ronald V. Miller, Jr.

Our lawyers are reviewing Philadelphia sex abuse lawsuits involving schools, churches, juvenile detention facilities, residential programs, youth organizations, public institutions, and other organizations that failed to protect children or vulnerable adults from sexual abuse.

In this post, we will look at Philadelphia sex abuse lawsuits. We will explain how sex abuse claims work under Pennsylvania law, who may be held responsible, how the filing deadline works, and what compensation may be available. We will also look at Philadelphia schools, churches, detention facilities, and other institutions that have faced sexual abuse claims.

If the abuse happened years ago, do not assume that you are automatically out of time. Pennsylvania has changed its statute of limitations for sexual abuse claims more than once, and whether an older claim is still viable can depend on the victim’s age, when the abuse occurred, and whether the claim had already expired when the law changed.

September 30, 2026

Hair Relaxer Lawsuit

by Ronald V. Miller, Jr.

Our lawyers are reviewing hair relaxer cancer lawsuits for women across the United States. These claims involve women who used chemical hair relaxers or hair straighteners for years and were later diagnosed with uterine cancer, including endometrial cancer, ovarian cancer, or serious uterine fibroids that led to a hysterectomy.

The federal hair relaxer litigation now includes nearly 12,000 plaintiffs. The cases are moving through expert discovery and bellwether preparation in the Northern District of Illinois. No hair relaxer settlement has been announced, and no plaintiff has received a settlement payout through the federal MDL. The latest hair relaxer lawsuit update is that Judge Mary Rowland has lifted a discovery stay for a group of defendants after concluding that settlement discussions had not produced enough progress to justify keeping those cases frozen.

The strongest cases generally involve frequent, long-term use followed by uterine or ovarian cancer, a clear product history, and substantial treatment or reproductive injury.

September 28, 2026

Suboxone Tooth Decay Lawsuit Update

by Ronald V. Miller, Jr.

This page explains the Suboxone tooth decay lawsuits, the dental injuries linked to Suboxone film, and where the federal MDL stands in 2026.

The core claim in the Suboxone litigation is straightforward: plaintiffs allege that Indivior and related defendants knew, or should have known, that Suboxone film could cause severe dental damage, including tooth decay, enamel erosion, broken teeth, tooth loss, and expensive dental reconstruction. Plaintiffs contend the companies failed to warn patients and prescribing doctors until the FDA forced a dental warning in 2022.

Contact Us About a Suboxone Tooth Decay Lawsuit

September 28, 2026

Benzene Lawsuits and Acute Myeloid Leukemia

by Ronald V. Miller, Jr.

You may be here because you or someone in your family has been diagnosed with acute myeloid leukemia (AML) or another blood cancer after years of benzene exposure. Benzene lawsuits most often focus on AML and related blood cancers linked to workplace or product exposure. These conditions are devastating on their own. When they are tied to a toxic chemical like benzene, the frustration is even greater.

Benzene has been tied to cancer for decades. The research is clear. Workers have brought benzene exposure lawsuits across the country, and juries have awarded significant verdicts in many cases. Families have negotiated benzene lawsuit settlements after showing that their exposure on the job or in the community caused leukemia, multiple myeloma, or other blood-related diseases.

If you are considering a benzene lawsuit, you are likely wondering how the process works, whether your case qualifies, and what kind of compensation is possible. The answers are specific to your situation, but the starting point is always the same: understanding how exposure happens and how the law allows victims to bring claims.

September 25, 2026

Gabapentin Dementia Lawsuit

by Ronald V. Miller, Jr.

Gabapentin lawsuits are now being investigated because new research has raised concerns that long-term or repeated gabapentin use is linked to dementia, mild cognitive impairment, memory loss, confusion, and other cognitive problems.

These cases are still developing, and we are in the early rounds of this. There is no nationwide gabapentin dementia class action lawsuit or MDL and there have not been any settlements. In fact, we are unaware of a single lawsuit filed in the U.S. alleging Gabapentin causes these injuries. But the science is advancing quickly, and the deeper our lawyers dig into these cases, the more we believe in them.

If you are reading this and are not a patient on Gabapentin, let’s talk briefly about what it is. Gabapentin is one of the most commonly prescribed medications in the United States. It is sold under the brand name Neurontin and is also available as a generic. Doctors prescribe Neurontin for seizures, shingles-related nerve pain, and a long list of off-label conditions, including back pain, neuropathy, anxiety, migraines, fibromyalgia, sleep problems, and other chronic pain complaints.

September 25, 2026

Chowchilla Women’s Prison Sex Abuse Lawsuit

by Ronald V. Miller, Jr.

Survivors of the Central California Women’s Facility (or Chowchilla Women’s Prison) have filed civil lawsuits alleging pervasive sexual abuse by correctional staff, detailing coercion, unwanted physical contact, and retaliation for reporting misconduct.

These claims underpin a growing wave of litigation seeking to hold the California Department of Corrections and Rehabilitation (CDCR) accountable and get much-deserved settlement compensation for victims. What we have learned about Chowchilla is that there was a stark pattern of institutional neglect on many levels. Male guards were sexually assaulting women, and administrators turned a blind eye.

There have been no mass settlements of the Chowchilla sexual assault lawsuit. But our lawyers believe in these cases and, while nothing is guaranteed, we think this Chowchilla Women’s Prison lawsuit could result in one of the largest prison-related abuse settlements in U.S. history.

September 25, 2026

Olympus Scope Lawsuit

by Ronald V. Miller, Jr.

Between 2013 and 2024, contaminated Olympus duodenoscopes infected hundreds of patients at hospitals across the United States. At least 35 people died from these medical scopes.

What happened? These awful infections were caused by dangerous, drug-resistant bacteria that were extremely difficult to treat.

So you had patients who went to the hospital, often getting diagnostic or therapeutic procedures that they did not think would be a big deal, only to come out with infections that damaged organs, required months of intensive care, or, tragically, proved fatal.

September 24, 2026

Gambling Addiction Lawsuits

by Ronald V. Miller, Jr.

Our lawyers are primarily investigating gambling addiction lawsuits involving DraftKings and FanDuel.

These lawsuits revolve around the idea that these companies had the data to identify compulsive gambling behavior. Did they use that data to protect gambling addicts or did they use this information to target them?

No, just the opposite. Instead of slowing vulnerable users down, DraftKings, FanDuel, and other defendants allegedly saw them as cash cow targets and pushed bonus bets, deposit matches, and anything else they could to keep them addicted and burning money on their betting apps. So the issue at trial is whether the platform used design, data, and marketing to keep a vulnerable user betting when a responsible operator should have stepped in.